NCT00986713Unknown4 期
Value of Amphotericin B Inhalation for Prophylaxis of Invasive Pulmonary Aspergillosis After Renal Transplantation
Capital Medical University1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2008年6月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 4 期
- 发起方
- 入组人数
- 400
- 试验地点
- 1
- 主要终点
- invasive pulmonary aspergillosis
研究概览
简要总结
The purpose of this study is to determine whether inhalation with aerosolized amphoterin B 10mg/d is more effective than aerosolized amphoterin B 2mg/d to reduce the incidence of invasive pulmonary aspergillosis.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •65ys≥age≥18ys
- •renal transplant recipients
排除标准
- •subjects with hypersensitivity to amphotericin B
- •receipt of inhalational or intravenous amphotericin B within last 30 days
- •subjects with known invasive fungal infection before renal transplant
- •subjects with pneumonia
结局指标
主要结局
invasive pulmonary aspergillosis
时间窗: 3 years
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
A observational study for effects of Amphotericin B in two different doses in Post Kala-Azar Dermal Leishmaniasis (PKDL)CTRI/2016/05/006958Intramural Projects of RMRIMS ICMR50
已完成
4 期
Amphotericin B to Treat Visceral Leishmaniasis in Brazilian ChildrenVisceral LeishmaniasisNCT01032187University of Brasilia101
已完成
3 期
Amphotericin B Suspension in Refractory Chronic SinusitisChronic SinusitisNCT00425620Accentia Biopharmaceuticals300
已完成
2 期
Combined Inhalational With Intravenous Amphotericin B Versus Intravenous Amphotericin B Alone for Pulmonary MucormycosisPulmonary MucormycosisNCT04502381Post Graduate Institute of Medical Education and Research, Chandigarh30
已完成
3 期
Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-BAI in Pediatric AsthmaticsAsthmaNCT00308685Teva Branded Pharmaceutical Products R&D, Inc.95